Pharmaceutical Policy Part 2 Pharmaceutical engagement and policy development: a framework for influence
نویسندگان
چکیده
منابع مشابه
Pharmaceutical Policy Part 2 Pharmaceutical engagement and policy development: a framework for influence
The formulation of pharmaceutical policy is a critical component of healthcare planning, made more important given that medicines are the ubiquitous technology in the diagnosis, treatment and prevention of disease and constitute a significant proportion of health care expenditure. Pharmacists need to inform policy development that will, in its implementation, offer opportunity to deliver greate...
متن کاملPharmaceutical policy Part 1 The challenge to pharmacists to engage in policy development
Across the world medicines are the ubiquitous technology in the diagnosis, treatment and prevention of disease. Pharmaceutical policy, as part of national health care policy, is concerned with the provision and use of medicines. Pharmacists are critical to the medicines management process, yet are often largely detached from policy development. Logically, they should inform Government policies ...
متن کاملPublic Policy and Pharmaceutical Innovation
Historically, new drug introductions have played a central role in medical progress and the availability of cost-effective therapies. Nevertheless, public policy toward pharmaceuticals has been characterized in recent times by increasingly stringent regulatory controls, shorter effective patent terms, and increased encouragement of generic product usage. This has had an adverse effect on the in...
متن کاملPharmaceutical Price Control Policy, Pharmaceutical Innovation, and Health Durability
Background: The increase in R&D and upward trend of R&D/pharmaceutical sales has occurred despite government controlled pharmaceutical price reduction in Japan. This paper identifies the effect of the government’s price control policy on pharmaceutical innovation and evaluates the influence of new chemical entities (NCE) on health
متن کاملPharmaceutical policy reform in Spain
Nevertheless, it is clear that some initial steps that will change the institutional foundations of health care financing have been taken. The introduction of the federal fund and the (however limited and contested) convergence between SHI and PHI point to an evolutionary change from competitive corporatism to the marketisation of health care (financing), accompanied by a changing role for stat...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Pharmaceutical Policy and Practice
سال: 2015
ISSN: 2052-3211
DOI: 10.1186/s40545-015-0026-6